How Decentralized Clinical Trials Are Delivering Time And Cost Efficiencies
A modeling study, an analysis of a dozen clinical trials and a survey of 400 clinical trial executives all show how using decentralized elements in trials can result in faster, less expensive and more engaging research.
You may also be interested in...
Decentralized Clinical Trials ‘No Longer A Leap Of Faith’
This second segment of a two-part Pink Sheet article on decentralized clinical trials looks at ensuring that staff at study sites are on onboard to support fast-paced change in this field, how regulatory guidance can help tackle hesitancy, and the need to transparently track such studies.
Decentralized Trial Technologies An ‘Encumbrance’ For Site Personnel, US Survey Shows
The Association of Clinical Research Professionals says the perspective of personnel working at clinical research sites must be taken into account to ensure the effective implementation of decentralized clinical trials.
COVID-19 Outlook: Variants, Boosters, And Being ‘Worse Off’ For Next Pathogens
US FDA’s Peter Marks, Pfizer’s Mikael Dolsten and other experts discuss what is being done to prepare for the future, worries about higher fatality rates, and what 2023 might look like.